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Data from a variety of experimental models suggest that natural killer (NK) cells require signals from accessory cells in
order to respond optimally to pathogens, but the precise identity of the cells able to provide such signals depends
upon the nature of the infectious organism. Here we show that the ability of human NK cells to produce interferon-c in
response to stimulation by Plasmodium falciparum–infected red blood cells (iRBCs) is strictly dependent upon multiple,
contact-dependent and cytokine-mediated signals derived from both monocytes and myeloid dendritic cells (mDCs).
Contrary to some previous reports, we find that both monocytes and mDCs express an activated phenotype following
short-term incubation with iRBCs and secrete pro-inflammatory cytokines. The magnitude of the NK cell response (and
of the KIR
  CD56
bright NK cell population in particular) is tightly correlated with resting levels of accessory cell
maturation, indicating that heterogeneity of the NK response to malaria is a reflection of deep-rooted heterogeneity in
the human innate immune system. Moreover, we show that NK cells are required to maintain the maturation status of
resting mDCs and monocytes, providing additional evidence for reciprocal regulation of NK cells and accessory cells.
However, NK cell–derived signals are not required for activation of accessory cells by either iRBCs or bacterial
lipolysaccharide. Together, these data suggest that there may be differences in the sequence of events required for
activation of NK cells by non-viral pathogens compared to the classical model of NK activation by virus-infected or
major histocompatibility complex–deficient cells. These findings have far-reaching implications for the study of
immunity to infection in human populations.
Citation: Newman KC, Korbel DS, Hafalla JC, Riley EM (2006) Cross-talk with myeloid accessory cells regulates human natural killer cell interferon-c responses to malaria. PLoS
Pathog 2(12): e118. doi:10.1371/journal.ppat.0020118
Introduction
After years of neglect, in which the adaptive immune
response to malaria was investigated in great depth with a
view to rational development of antimalarial vaccines, the
innate immune response to malaria has recently come under
scrutiny. In part, this is driven by the realisation that innate
immune responses initiate and mould the subsequent
adaptive response and that understanding the innate immune
response may aid the design of novel adjuvants and novel
vaccine delivery systems. Furthermore, data from experi-
ments in rodents and from clinical studies indicate that
innate immune responses play a crucial role in controlling
malaria infections [1] and can signiﬁcantly alter the outcome
of infection, especially in non-immune individuals. The key
element in the cell-mediated effector response to malaria is
the rapid induction of interferon (IFN)–c [2–6]. We have
shown that human natural killer (NK) cells can be an
important early source of IFN-c after exposure of leukocytes
to Plasmodium falciparum–infected red blood cells (iRBCs) [7–
9], although this response is extremely heterogeneous [8,9].
Emerging data suggest that signals from accessory cells such
as macrophages, monocytes, and dendritic cells (DCs) are
absolutely required for optimal NK cell responses to many
infectious agents [10–12]. Consistent with this, we have
previously demonstrated that cloned NK cells are unable to
respond to iRBCs in the absence of autologous peripheral
blood mononuclear cells (PBMCs) [8]. However, an essential
role for accessory cells in promoting robust pro-inﬂamma-
tory responses to malaria is somewhat controversial given
previous observations suggesting that accessory cell function
is seriously impaired by exposure to malarial parasite ligands.
For example, following exposure to iRBCs, both human DCs
and monocytes secrete the immunosuppressive cytokine
interleukin-10 (IL-10) [13,14], have an impaired ability to
mature in response to lipopolysaccharides (LPS) and other
ligands [13,15–17], and are unable to present antigen to T
cells [13]. Moreover, DCs from children with acute malaria
infection have reduced human leukocyte antigen (HLA)–DR
expression [18].
Here we have assessed the precise contribution of various
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demonstrate that cells of the myeloid lineage are not only
activated by iRBCs, but also play a crucial role in controlling
the magnitude of the early burst of NK cell–derived IFN-c via
both cytokine- and contact-dependent signals. Furthermore,
we provide evidence that reciprocal interactions between NK
cells and myeloid accessory cells regulate levels of activation
of both cell populations, with major implications for the
ability of the innate immune system to recognise and respond
to infection.
Materials and Methods
Blood Donors
Adult blood donors were recruited at the London School of
Hygiene and Tropical Medicine through an anonymous blood
donation system. All donors were malaria naı ¨ve and healthy
and gave fully informed consent for their blood to be used in
this study. Ethical approval was given by the London School
of Hygiene and Tropical Medicine Ethics Committee,
application number 805. As we have previously shown that
NK cells from only some donors make a strong IFN-c
response to iRBCs [7–9], cells from known high-responding
donors were used for the majority of experiments described
here.
P. falciparum Culture and Antigen Preparation
P. falciparum parasites (strain 3D7) were grown in O
Rh 
human erythrocytes (National Blood Service, http://www.
blood.co.uk) in RPMI 1640 (Gibco, http://www.invitrogen.
com/content.cfm?pageid¼11040) supplemented with 25 mM
HEPES (Sigma-Aldrich, http://www.sigmaaldrich.com), 28 mM
sodium bicarbonate (BDH, http://uk.vwr.com), 20 lg/l hypo-
xanthine (Sigma-Aldrich), and 10% normal human AB serum
(National Blood Service). Cultures were gassed with 3% O2,
4% CO2, and 93% N2 and incubated at 37 8C. The culture
medium was changed daily and the parasitaemia was
determined by examination of Giemsa-stained thin blood
smears. Parasite cultures were routinely shown by PCR
(Stratagene, http://www.stratagene.com) to be free from
Mycoplasma contamination. Mature schizonts were harvested
from cultures of 5%–8% parasitaemia by centrifugation
through a 60% Percoll gradient (Sigma-Aldrich).
PBMC Preparation and Culture
Venous blood was collected into sodium heparin (10 IU/ml
blood; CP Pharmaceuticals, http://www.wockhardt.co.uk) and
PBMCs were isolated by Histopaque 1077 (Sigma-Aldrich)
density gradient centrifugation as described previously [9].
Cells were resuspended at a concentration of 10
6 cells/ml and
cultured in ﬂat-bottomed 24-well plates for 24 h. Schizont-
infected (iRBCs) or uninfected red blood cells (uRBCs) were
added at a ratio of three red blood cells per mononuclear cell.
Cell Surface and Intracellular Staining for Flow Cytometry
Surface and intracellular staining was performed as
described previously [9]. The antibodies used were anti-CD3
PerCP, IgG1 PerCP, and anti-HLA-DR PerCP (all from BD
Biosciences, http://www.bdbiosciences.com); anti-CD11c Alex-
aFluor-647, IgG1 AlexaFluor-647, anti-CD56 AlexaFluor-647,
IgG2a AlexaFluor-647, anti-IFN-c FITC, anti-CD14 FITC,
IgG1 FITC, anti-CD40 R-PE, anti-CD69 R-PE, IgG2a R-PE,
anti-CD80 R-PE-Cy5, and IgG1 R-PE-Cy5 (all from Serotec,
http://www.serotec.com). Flow cytometric analyses were per-
formed using a Becton Dickinson FACSCalibur ﬂow cytom-
eter (BD Biosciences) and FlowJo analysis software (TreeStar,
http://www.treestar.com).
NK Cell Purification
CD56
þ CD3
  NK cells were enriched from PBMCs by
magnetic cell separation (NK Cell Enrichment kit; StemCell
Technologies, http://www.stemcell.com) according to the
manufacturer’s instructions and using LS separation columns
(Miltenyi Biotec, http://www.miltenyibiotec.com). B cells, T
cells, monocytes, and erythrocytes were retained in the
column, and the efﬂuent containing unlabelled NK cells was
collected. NK cells were counted, tested for viability by trypan
blue exclusion, and routinely checked by ﬂow cytometry for a
purity of greater than 95%.
Depletion of Accessory Cells or NK Cells
PBMCs were depleted of different populations using
monoclonal mouse antibodies to human HLA-DR (Scottish
Antibody Production Unit, United Kingdom), CD14 (Sero-
tec), or BDCA-4 (Miltenyi Biotec), and goat anti-mouse IgG
MicroBeads (Miltenyi Biotec); CD19 MicroBeads (Miltenyi
Biotec); biotinylated CD1c (BDCA-1) antibody and anti-biotin
MicroBeads (Miltenyi Biotec); or CD56 positive selection kit
(StemCell Technologies).
Transwell Cultures
PBMCs (1310
6) in a volume of 800 ll of complete medium
were placed in a tissue culture well. Puriﬁed NK cells (1310
5)
in a volume of 200 ll were placed in a Transwell with a 0.4-lm
microporous polycarbonate membrane (Corning, http://www.
corning.com) and lowered into the culture well so that all
cells were submerged in culture medium. iRBCs (3 3 10
6,
bottom well, or 0.5 3 10
6, top well) were added as indicated.
Plates were cultured for 24 h, and NK cells from the top well
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Synopsis
The outcome of infection is determined both by the ability to limit
the initial phase of pathogen colonisation and by the ability to
mount an effective adaptive immune response. Both of these
processes are influenced by innate immune responses, of which a
crucial component can be the ability of natural killer (NK) cells to
secrete pro-inflammatory cytokines. Studies in both humans and
mice indicate that the magnitude of the early (innate) interferon
(IFN)–c response is a crucial determinant of the outcome of malaria
infection. In this study, Newman et al. show that activation of human
NK cells by Plasmodium falciparum–infected red blood cells to
produce IFN-c is strictly dependent upon, and regulated by, contact-
mediated and soluble (cytokine) signals from two accessory cell
populations (myeloid dendritic cells and monocytes). Furthermore,
the magnitude of the human NK cell IFN-c response to P.
falciparum–infected red blood cells is highly correlated with levels
of expression of co-stimulatory molecules on resting accessory cells.
These findings suggest that it might be possible to predict the
magnitude of the innate cytokine response, and possibly even
susceptibility to malarial disease, from the phenotype of resting
monocytes. In addition, these data contribute to the development
of a new model of NK activation by non-viral pathogens in which
activation of accessory cells precedes, rather than follows, NK
activation.Figure 1. NK Cells Do Not Respond to iRBCs in the Absence of Accessory Cells
PBMCs or MACS-purified NK cells from malaria-naı ¨ve donors were cultured alone or with IL-12 and IL-18, uRBCs, or live iRBCs for 24 h. Intracellular IFN-c
and surface expression of CD69 on CD3
  CD56
þ NK cells were analysed by flow cytometry.
(A and B) Representative example of NK responses to uRBCs, IL-12 and IL-18, and iRBCs in PBMCs (A) and purified NK cells (B). FACS plots are gated on
CD3
  CD56
þ lymphocytes. Percentages indicate the proportion of CD3
  CD56
þ NK cells in each gate; data are based on the collection of 100,000 total
events.
(C and D) Comparison of NK responses to iRBCs in PBMCs and in purified NK cells. (C) NK cell IFN-c production for six donors. (D) CD69 surface
expression levels for seven donors. **, p , 0.01; ***, p , 0.001; p-values are for paired t tests comparing stimulated and unstimulated NK cells from the
same donor, or PBMCs and pure NK cells from the same donor.
(E) MACS-purified, CTG-labelled NK cells were added to autologous PBMCs. IFN-c production in CTG
þ(MACS-purified) and CTG
 (‘‘untouched’’) NK cells
was assessed by flow cytometry after 24 h of stimulation with iRBCs. A representative example of the software gating strategy to analyse IFN-c
responses of CTG-labelled NK cells is shown. FACS plots were gated on CD3
 CD56
þNK cells within the lymphocyte population (first panel), and NK cells
were analysed for CTG staining (second panel). CTG
þ CD3
  CD56
þ NK cells (third panel) or CTG
  CD3
  CD56
þ NK cells (fourth panel) were selected and
analysed for intracellular IFN-c production. Numbers indicate the proportion of IFN-c
þ NK cells.
doi:10.1371/journal.ppat.0020118.g001
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Accessory Cells in NK Response to P. falciparumand/or PBMCs from the bottom well were harvested, stained,
and analysed by ﬂow cytometry as previously described.
Recombinant Cytokines and LPS
In all experiments a combination of human recombinant
IL-12 (Peprotech, http://www.peprotech.com) and human
recombinant IL-18 (MBL International, http://www.mblintl.-
com), each at 0.1 lg/10
6 cells, was used as a positive control.
Bioactive human recombinant transforming growth factor
(TGF)–b (R&D Systems, http://www.rndsystems.com) was used
at the concentrations indicated. LPS puriﬁed from Escherichia
coli (Sigma-Aldrich) were used at a concentration of 1 lg/10
6
cells.
Cytokine Blocking
The following neutralising antibodies were used to block
cytokines or their respective receptors: polyclonal rabbit
anti-human IL-2 (Serotec), polyclonal rabbit anti-human IL-
15 (Biosource, http://www.biosource.com), monoclonal
mouse anti-human IFN-a/b receptor chain 2 (Chemicon,
http://www.chemicon.com), and polyclonal chicken anti-
TGF-b (R&D Systems). The antibodies or their respective
isotype-matched controls were added to PBMC cultures
prior to the addition of iRBCs and at the concentrations
indicated.
Quantification of Cytokine mRNA by Real-Time
Quantitative PCR
For each donor, 10
7 PBMCs were cultured for 24 h in the
presence or absence of 3 3 10
7 iRBCs. Non-adherent cells
were discarded and adherent cells harvested after 15 min
incubation on ice followed by scraping. Total RNA was
isolated (RNeasy Micro kit; Qiagen, http://www1.qiagen.com)
and cDNA was produced using oligo(dT)12–18mer primers and
SuperScript III reverse transcriptase (Invitrogen, http://www.
invitrogen.com) according to the manufacturer’s instructions.
Real-time quantitative PCR (ABI Prism 7000; Applied
Biosystems, http://www.appliedbiosystems.com) was carried
out using QuantiTect SYBR Green (Qiagen) and the following
primers: b-actin (59-ACCCAGATCATGTTTGAGACCT-39
and 59-TCCATCACGATGCCAGTG-39), IL-2 (59-
AGTCCCTGGGTCTTAAGTGAAAG-39 and 59-CAA-
GAAGGCCACAGAACTGAA-39), IL-10 (59-
TCTGGGTCTTGGTTCTCAGC-39 and 59-TGGAGGACTT-
TAAGGGTTACCTG-39), IL-12a (encodes p35 subunit) (59-
CTCCAGAAGGCCAGACAAAC-39 and 59-AATGGTAAA-
CAGGCCTCCACT-39), IL-15 (59-TGATGTTCACCC-
CAGTTGC-39 and 59-TTCCTCACATTCTTTGCATCC-39),
IL-18 (59-CAGACCTTCCAGATCGCTTC-39 and 59-
GGGTGCATTATCTCTACAGTCAGAA-39), IL-23 (59-
GTGGGACACATGGATCTAAGAGA-39 and 59-
GGATCCTTTGCAAGCAGAAC-39), IFN-a (59-
GCCATCTCTGTCCTCCATGA-39 and 59-CAT-
GATTTCTGCTCTGACAACCT-39), and IFN-c (59-
TTCGGTAACTGACTTGAATGTCC-39 and 59-
TCTTCGACCTTGAAACAGCA-39).
TGF-b ELISA
The concentration of total (bioactive and latent) and
spontaneously bioactive TGF-b in culture supernatants was
assessed using the Human TGF-b 1 DuoSet system (R&D
Systems) according to the manufacturer’s instructions.
Figure 2. HLA-DR
þ Accessory Cells Provide Activating Signals to NK Cells
PBMCs from malaria-naı ¨ve donors were depleted of different populations
of accessory cells, and NK cell responses to iRBCs were analysed after 24 h
of co-culture.
(A) Representative example of NK cell IFN-c responses in undepleted
PBMCs (top left), PBMCs depleted of all HLA-DR
þ antigen-presenting cells
(APC) (top right), CD14
þ monocyte–depleted PBMCs (middle left), CD19
þ
B cell–depleted PBMCs (middle right), CD1c
þ mDC–depleted PBMCs
(bottom left), and BDCA-4
þ pDC–depleted PBMCs (bottom right). FACS
plots are gated on CD3
  CD56
þ lymphocytes. Percentages indicate the
proportion of CD3
  CD56
þ NK cells that were positive for IFN-c; data are
based on the collection of 100,000 total events.
(B) NK cell IFN-c production after depletion of different antigen-
presenting cell populations. Percentage of IFN-c NK cells relative to the
response in undepleted PBMCs is shown; each spot represents data for a
different donor. *, p , 0.05; ***, p , 0.0001; p–values are for paired t tests
of the difference between depleted and undepleted cells:
doi:10.1371/journal.ppat.0020118.g002
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Multiplex quantiﬁcation of cytokine concentrations in
tissue culture supernatants was performed using the Luminex
100 system (Luminex, http://www.luminexcorp.com) with Bio-
Plex upgrade (Bio-Rad Laboratories, http://www.bio-rad.com).
Levels of IL-2, IL-10, and IL-12p70 were determined using the
Beadlyte Human Multi-Cytokine Detection System 3 (Up-
state, http://www.upstate.com) according to the manufac-
turer’s instructions. Data analysis was performed using the
Bio-Plex Manager software (Bio-Rad).
Statistical Analysis
All statistical analyses were performed using Prism 4
software (GraphPad Software, http://www.graphpad.com). All
r
2 values given refer to a second-order polynomial ﬁt of data
shown. If data are plotted using log scale, analysis was carried
out using log values. All t tests carried out were two-tailed
paired t tests with 95% conﬁdence intervals. Comparisons
were made between actual data even where log axes have
been used to plot data.
Results
Optimal NK Cell Response to iRBCs Is Accessory Cell–
Dependent
We have previously shown that cloned NK cell lines are
unable to respond to iRBCs in the absence of accessory cells
that are present among PBMCs [8]. To conﬁrm and extend
this observation, NK cells were puriﬁed from PBMCs of seven
different donors by magnetic cell sorting (MACS) and
stimulated for 24 h with IL-12 and IL-18, uRBCs, or iRBCs
or left unstimulated and analysed for surface expression of
CD3, CD56, CD69, and intracellular IFN-c; unsorted PBMCs
from the same donors were stimulated and analysed in an
equivalent fashion (Figure 1). In PBMC cultures, as expected,
IFN-c
þ (CD3
  CD56
þ) NK cells were detected in both
cytokine-stimulated and iRBC-stimulated cultures but not
in unstimulated or uRBC-stimulated cultures (Figure 1A). We
deliberately selected donors who were known, from previous
studies, to be relatively high responders in this assay;
nevertheless, the magnitude of the IFN-c response to iRBCs
varied between donors, with between 5% and 50% of NK cells
making IFN-c in response to iRBCs after 24 h (Figure 1C). In
complete contrast, although puriﬁed NK cells made IFN-c in
response to cytokine stimulation (Figure 1B), no IFN-c was
produced by puriﬁed NK cells in response to iRBCs (Figure
1B and 1C).
We have shown that up-regulation of surface CD69
expression is a marker of partial (early) activation of NK
cells [9], and thus, as expected, up-regulation of CD69 was
consistently seen on NK cells within the iRBC-stimulated
PBMC population (Figure 1D). Surface CD69 expression
tended to be higher on unstimulated puriﬁed NK cells than
on unstimulated NK cells within PBMCs, presumably because
of partial activation during cell separation. However, CD69
surface expression was not signiﬁcantly up-regulated on
puriﬁed NK cells after stimulation with iRBCs, and NK CD69
expression was signiﬁcantly higher among iRBC-stimulated
PBMC NK cells than among puriﬁed NK cells (Figure 1D).
Importantly, the inability of puriﬁed NK cells to respond to
iRBCs is not an artefact of the NK cell puriﬁcation process as
MACS-puriﬁed NK cells labelled with CellTracker Green
(CTG) and added back to autologous PBMC cultures respond
as well to iRBC stimulation as do ‘‘untouched’’ NK cells
within PBMCs (Figure 1E).
Thus, these data indicate that accessory cells within PBMCs
are required for both IFN-c and CD69 expression among
iRBC-stimulated NK cells.
Depletion of CD1c
þ and CD14
þ Accessory Cells Inhibits
the NK Cell Response
To identify the accessory cell population(s) required for
NK cell activation by iRBCs, PBMCs of known high-respond-
ing donors were depleted (by MACS) of cells expressing
speciﬁc cell surface markers prior to incubation with iRBCs
(Figure 2). PBMCs of all the donors tested in these experi-
ments responded to iRBC stimulation, with 5%–40% of all
NK cells producing IFN-c after 24 h. Depletion of accessory
cell populations did not affect the ability of NK cells to
produce IFN-c following stimulation with positive control
stimuli (IL-12 and IL-18; Figure S1). Depletion of HLA-DR
þ
cells completely abolished the NK cell IFN-c response to
iRBCs in all donors, but depletion of BDCA-4
þ plasmacytoid
DCs (pDCs) had no consistent effect on the NK IFN-c
response. Likewise, depletion of CD19
þ B cells did not reduce
the NK cell IFN-c response. However, depleting PBMCs of
either CD1c
þ myeloid DCs (mDCs) or CD14
þ monocytes
signiﬁcantly reduced NK cell IFN-c responses (monocytes,
paired t test, t¼3.63, p¼0.036; mDCs, paired t test, t¼3.82, p
¼0.032). In the one donor where depletion using either CD14
or CD1c did not substantially reduce the IFN-c response
(relative response, monocyte-depleted ¼ 0.84, mDC-depleted
¼0.90), a double depletion using both antibodies together was
performed. In this case the IFN-c response was substantially
reduced (relative response ¼ 0.32).
These data indicate that the NK cell response to iRBCs is
not dependent on a single population of accessory cells;
rather, both mDCs and monocytes can provide activating
signals for NK cells, and, in most donors, optimal NK
activation requires both of these cell types to be present.
Monocytes and mDCs Are Activated by iRBCs
Given the numerous published reports indicating that
monocyte and DC function is inhibited by exposure to iRBCs
[13,14], it was important to determine whether the accessory
cells required for NK cell activation were themselves
activated by exposure to iRBCs. PBMCs from ten different
donors were therefore stimulated with uRBCs, iRBCs, or E.
coli LPS (or left unstimulated, growth medium alone [gm]) for
24 h, and then mDC and monocyte populations were analysed
for expression of the activation markers CD40, HLA-DR, and
CD80 (Figure 3; isotype control data to exclude non-speciﬁc
binding of labelled antibodies by activated accessory cells are
shown in Figure S2).
Signiﬁcant up-regulation of CD40, CD80, and HLA-DR was
observed on monocytes from all donors following 24 h
incubation with iRBCs (CD40, mean fold increase of median
ﬂuorescence intensity [MFI] ¼ 6.3, paired t test, t ¼ 3.59, p ¼
0.006; HLA-DR, mean fold increase of MFI¼1.7, paired t test,
t ¼ 3.42, p ¼ 0.008; CD80, mean fold increase of MFI ¼ 3.0,
paired t test, t¼7.56, p , 0.0001). Activation of mDCs was also
observed, with signiﬁcant up-regulation of CD40 and HLA-
DR expression (CD40, mean fold increase of MFI¼2.3, paired
t test, t¼3.60, p¼0.006; HLA-DR, mean fold increase of MFI¼
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PBMCs from ten malaria-naı ¨ve donors were cultured with live iRBCs or E. coli LPS for 24 h or left unstimulated. Surface expression of HLA-DR, CD40, and
CD80 on accessory cells was analysed by flow cytometry.
Accessory cells were defined as HLA-DR
þ CD11c
þ cells (A, left), and CD14
þ monocytes and CD14
  mDCs were selected for further analysis (A, right).
Representative examples of surface expression levels of CD40, HLA-DR, and CD80 on HLA-DR
þ CD11c
þ CD14
þ monocytes (B) and HLA-DR
þ CD11c
þ
CD14
 mDCs (C) are shown. Data are based on the collection of 100,000 total events. Results for all ten donors are summarised in (D). *, p , 0.05; **, p ,
0.01; ***, p , 0.001; p-values are for paired t tests comparing stimulated and unstimulated cells from the same donor.
doi:10.1371/journal.ppat.0020118.g003
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Accessory Cells in NK Response to P. falciparum2.4, paired t test, t ¼ 3.16, p ¼ 0.012). There was, however, no
signiﬁcant change in expression of CD80 on mDCs after 24 h
co-incubation with iRBCs (mean fold increase of MFI ¼ 1.3,
paired t test, t ¼ 2.04, p ¼ 0.072).
These data indicate that both mDCs and monocytes are
activated after 24 h co-incubation with iRBCs but that the
nature of activation differs between the two accessory cell
populations. Up-regulation of CD40 is more pronounced in
monocytes and up-regulation of HLA-DR is more pro-
nounced in mDCs, whilst up-regulation of CD80 occurs
exclusively in monocytes.
Accessory Cells Express Both Pro- and Anti-Inflammatory
Cytokines in Response to Activation by iRBCs
To characterise further the activation of accessory cells by
iRBCs, we analysed the cytokine response proﬁle after
culturing PBMCs for 24 h with iRBCs by quantitative real-
time PCR analysis of adherent cells and by Luminex cytokine
bead array analysis of culture supernatants (Figure 4).
Unstimulated adherent cells expressed detectable levels of
mRNA for IL-15, IL-18, and, at somewhat lower levels, IL-10,
IL-12, and IL-23, indicating either constitutive expression of
these cytokines or their induction during the cell separation
process. Levels of IFN-a, IL-2, and IFN-c mRNA were below
the limits of detection of the assay (Figure 4A). However, after
iRBC stimulation there was very marked up-regulation of
mRNA for IFN-a and IL-2 and, to a somewhat lesser extent,
for IL-10 and IFN-c but not for IL-12, IL-15, IL-18, or IL-23
(Figure 4B). Taken together, these data indicate constitutive
or induced expression of IL-12, IL-15, IL-18, IL-23, IFN-a, IL-
2, IL-10, and IFN-c by adherent mononuclear cells stimulated
with iRBCs. Production of IL-2, IL-10, and IL-12 in response
to iRBC stimulation was conﬁrmed at the protein level
(Figure 4C); the discrepancy between mRNA and protein
levels for IL-12 is most likely explained by the timing of the
assays (all of which were conducted after 24 h).
Type 1 IFN and IL-2, but Not IL-15, Are Required for NK
Cell Activation by iRBCs whilst TGF-b Suppresses This
Response
NK cell activation by pathogens is typically dependent on
accessory cell–secreted cytokines [19–22], and we have shown
that IL-12 and, to a somewhat lesser extent, IL-18 are required
for optimal NK responses to iRBCs [7,8]. To determine
whether other accessory cell–derived cytokines are also
required for NK activation, the response to iRBCs was
analysed in the presence or absence of neutralising antibodies
to individual cytokines or their receptors. Of particular
interest were those cytokines that we had found (as described
above) to be speciﬁcally and strongly upregulated by iRBCs,
namely IFN-a and IL-2. Also, since TGF-b has recently been
reported to be a powerful inhibitor of NK cell activation [23],
and since we have shown that induction of TGF-b in vivo in
both human and rodent malaria infections is associated with
lack of early IFN-c responses [24,25], it was of considerable
interest to determine whether TGF-b might regulate the NK
cell IFN-c response to iRBCs in our in vitro assay system where
platelets and mononuclear cells provide an abundant source
of latent TGF-b. Representative ﬂuorescence activated cell
sorting (FACS) plots showing the effect of blocking cytokines
on IFN-c response to iRBCs are shown in Figure S3.
In the presence of a blocking antibody to the IFN-a/b
receptor, there is a signiﬁcant and dose-dependent inhibition
of the NK cell IFN-c response to iRBCs (highest antibody
dose, paired t test, t ¼ 6.42, p ¼ 0.023) (Figure 5A) and a
similar, but less marked, reduction in CD69 expression
(highest antibody dose, paired t test, t ¼ 5.26, p ¼ 0.034)
(Figure S4). Similarly, neutralisation of IL-2 markedly
inhibited NK cell IFN-c responses in a dose-dependent
manner (highest antibody dose, paired t test, t ¼ 8.79, p ¼
0.001) (Figure 5B), and CD69 surface expression was also
reduced, but to a lesser degree (highest antibody dose, paired
t test, t ¼ 4.43, p ¼ 0.021) (Figure S4). On the other hand,
neutralisation of IL-15 had only a minimal effect on NK cell
IFN-c responses (highest antibody dose, paired t test, t¼1.83,
p ¼ 0.209) (Figure 5C) or CD69 expression (highest antibody
dose, paired t test, t ¼ 3.36, p ¼ 0.078) (Figure S4).
When PBMCs were incubated with iRBCs for 24 h in the
presence or absence of increasing doses of neutralising
Figure 4. Accessory Cell–Derived Cytokines Are Upregulated in
Response to iRBCs
(A and B) PBMCs from four donors were stimulated with iRBCs for 24 h,
and the amount of IFN-a, IL-2, IL-12, IL-15, IL-18, IL-23, IFN-c, and IL-10
mRNA in adherent cells was determined by real-time quantitative PCR.
The resting levels relative to the amount of b-actin mRNA are shown in
(A). The fold up-regulation in response to iRBC stimulation is shown in
(B).
(C) Cytokine levels in tissue culture supernatants were determined for
eight donors in a bead-based cytokine quantification assay. Levels of IL-2
(left), IL-10 (middle), and IL-12 (right) for no stimulation (gm), uRBC
stimulation, and iRBC stimulation are shown (arithmetic mean plus
standard error of the mean).
doi:10.1371/journal.ppat.0020118.g004
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Accessory Cells in NK Response to P. falciparumantibody to TGF-b, there was a highly consistent, dose-
dependent increase in the proportion of NK cells synthesis-
ing IFN-c, with up to a 3-fold increase in IFN-c
þ NK cells in
the presence of 100 lg/ml antibody (paired t test, t¼7.98, p¼
0.004) (Figure 5D) and a slight, but statistically signiﬁcant,
increase in CD69 expression (highest antibody dose, paired t
test, t ¼ 4.00, p ¼ 0.028) (Figure S4). Conversely, addition of
recombinant human TGF-b led to a very marked, dose-
dependent suppression of the NK cell IFN-c response to
iRBCs (highest dose, 1 ng/ml; paired t test, t ¼ 12.8, p ¼ 0.001;
unpublished data).
Optimal NK Cell Response to iRBCs Requires Contact
between NK Cells and Accessory Cells
For some microbial stimuli it has been reported that
optimal NK cell activation requires contact with accessory
cells [12,22,26,27]. We thus sought to determine whether such
contact-dependent signals were also required for NK activa-
tion by iRBCs. Puriﬁed NK cells (in the upper chamber of a
Transwell culture system) were separated from PBMCs (in the
lower chamber) by a microporous membrane (0.4-lm
diameter), which allowed diffusion of small molecules
including cytokines, but not migration of leukocytes, iRBCs,
or extracellular malarial merozoites. When a soluble positive
control stimulus (phytohaemagglutinin) was added to the
lower well, NK cells in the inner (top) well responded
normally, indicating that diffusion of soluble signals was not
impeded (Figure S5). When iRBCs were added to the lower
chamber, NK cells within the PBMC population synthesised
IFN-c (Figure 6A, PBMC control) and upregulated CD69
(Figure 6B, PBMC control). However, addition of iRBCs to the
upper well, the lower well, or both the upper and lower wells
together was insufﬁcient to induce optimal IFN-c production
among the NK cells in the upper well, suggesting that contact-
mediated interactions between NK cells and iRBCs and/or
between accessory cells and iRBCs are insufﬁcient for full NK
activation and that direct cell–cell contact between the NK
cells and the accessory cells is required.
Contact between NK cells and accessory cells was also
required for optimal up-regulation of CD69, although partial
up-regulation of CD69 was observed in some cases when
puriﬁed NK cells were in contact with iRBCs and/or when
accessory cells were in contact with iRBCs. The up-regulation
of CD69 by puriﬁed NK cells in the Transwell system (Figure
6), but not in regular cultures of puriﬁed NK cells (Figure 1),
is presumably due to the presence of soluble, cytokine-
mediated signals derived from PBMCs in the lower well.
NK Cell–Derived Signals Maintain the Maturation Status of
Accessory Cells but Are Not Required for Accessory Cell
Responses to iRBCs or LPS
In recent years it has become apparent that interactions
between NK cells and DCs can be bidirectional. NK cells,
especially those activated by prior exposure to IL-2, enhance
DC maturation, inﬂammatory cytokine secretion, and antigen
presentation in allogeneic situations and when exposed to
virus-infected cells [28–30]. On the other hand, the degree of
reciprocity between NK cells and monocytes, and the
potential for NK cells to augment accessory cell responses
to non-viral pathogens, has not to our knowledge been
investigated. We therefore examined whether the interac-
tions that we had observed to be crucial for the activation of
Figure 5. The NK Cell Response to iRBCs Is Controlled by Type 1 IFN, IL-2, and TGF-b
PBMCs from malaria-naı ¨ve donors were stimulated for 24 h with iRBCs in the presence of increasing concentrations of neutralising antibodies to (A) the
IFN-a/b receptor, (B) IL-2, (C) IL-15, or (D) TGF-b. Percentages of IFN-c NK cells relative to those observed with the respective concentration of isotype-
matched control antibodies are shown. Only donors known to make a strong IFN-c response to iRBCs were used; baseline percentages of NK cells that
were IFN-c
þ after iRBC stimulation ranged from 5% to 40% for the donors shown here.
doi:10.1371/journal.ppat.0020118.g005
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Accessory Cells in NK Response to P. falciparumNK cells by iRBCs led to reciprocal activation of either
monocytes or mDCs.
Whole PBMCs or PBMCs depleted of NK cells were
cultured for 24 h without stimulation (gm) or with LPS or
iRBCs. After 24 h, cells were stained for HLA-DR, CD14,
either CD40 or CD80, and either CD11c or CD11b (Figure
7A). Both mDCs and monocytes expressed signiﬁcantly lower
levels of activation markers when cultured (without addi-
tional stimulation) in the absence of NK cells (Figure 7B–7D),
conﬁrming a previous report of a role for NK cells in
promoting DC maturation [29] and extending this observa-
tion to monocytes. On the other hand, when cells were
cultured with either LPS or iRBCs, there was no signiﬁcant
effect of the presence or absence of NK cells on expression
levels of any of the activation markers in either mDCs or
monocytes (Figure 7B–7D). Thus, while NK cells play a role in
maturation of both monocytes and mDCs in resting con-
ditions, the response of either of these cell types to LPS or
iRBC stimulation is largely NK cell–independent. These data
suggest that, at this early time point, the major inducers of
myeloid cell activation are the pathogens themselves, rather
than NK-derived IFN-c.
Degree of Monocyte Activation Correlates with
Magnitude of NK Cell IFN-c Response
We have previously shown that human NK cell responses to
iRBCs are heterogeneous [8,9]. Here, we noticed a consid-
erable degree of heterogeneity of accessory cell surface
marker expression (Figure 3D) and of cytokine production
(Figure 4) among donors, in terms of both resting levels and
responses to iRBCs. Given the absolute dependence of the NK
cell response to iRBCs on accessory cells, we sought to
determine whether heterogeneity of NK cell responses
correlated with heterogeneity of accessory cell responses.
Since NK cell IFN-c responses can vary between CD56
bright
and CD56
dim NK cells—presumably because of differential
expression of NK cell receptors including the killer cell
immunoglobulin-like receptors (KIRs), which are expressed
by CD56
dim but not CD56
bright NK cells—we analysed the
correlation between accessory cell and NK cell responses for
both of these NK cell populations.
Highly signiﬁcant correlations were observed between
iRBC-induced concentrations of IL-12 (Figure 8A) and IL-2
(Figure 8B) and the magnitude of the NK cell IFN-c response.
A particularly close correlation was observed between IL-12
concentrations and the proportion of IFN-c
þ CD56
bright
(KIR
 ) cells, whilst, for several donors (see arrows in Figure
8), a signiﬁcant discrepancy was seen in the response of the
CD56
dim population. Somewhat surprisingly, there was no
correlation between iRBC-induced up-regulation of HLA-
DR, CD40, or CD80 on either monocytes or mDCs and NK
IFN-c production (unpublished data). However, resting levels
of expression of both CD40 and HLA-DR were tightly
correlated with the NK cell IFN-c response (Figure 8C and
8D). For resting levels of CD40 expression there was again a
much closer correlation with the IFN-c response of CD56
bright
NK cells than with that of CD56
dim NK cells. One plausible
interpretation of these data is that the NK cell IFN-c response
is very sensitive to accessory cell CD40 expression and IL-12
production, but that in CD56
dim cells this response is
moderated by KIR/major histocompatibility complex (MHC)
class I–mediated signals.
Our observation that TGF-b is able to markedly suppress
NK cell IFN-c responses (Figure 5) led us to consider whether
the heterogeneity of NK cell responses was due to differential
production and/or activation of TGF-b.T h e r ew a sn o
consistent increase or decrease in the concentration of
bioactive TGF-b in the supernatants of iRBC-stimulated
PBMCs; a modest increase in bioactive TGF-b concentration
was observed for two donors, but these were, in fact, the
donors with the highest NK cell IFN-c responses to iRBCs,
suggesting that suppression by TGF-b does not explain the
Figure 6. Contact between NK Cells and Accessory Cells Is Necessary for
an Optimal Response to iRBCs
Purified NK cells and autologous PBMCs were co-cultured in Transwell
plates, separated by a microporous membrane. The presence of iRBCs in
the respective compartments, purified NK cells in the top well and
PBMCs in the bottom well are indicated in the key to the figure.
Intracellular production of IFN-c (A) and surface expression levels of
CD69 (B) on NK cells in the top well were analysed by flow cytometry.
The black bars represent NK cell responses for PBMCs stimulated with
iRBCs. All other bars represent values for purified NK cells (upper well).
Percentages indicate the proportion of CD3
  CD56
þ NK cells that were
positive for IFN-c; data are based on the collection of 100,000 total
events.
doi:10.1371/journal.ppat.0020118.g006
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Accessory Cells in NK Response to P. falciparumheterogeneity of NK cell IFN-c response. Rather, regulation
of bioactive TGF-b appears to be positively correlated with
NK cell IFN-c expression (Figure 8E), and furthermore, the
correlation with CD56
dim NK cells was higher than that with
CD56
bright NK cells. This suggests that TGF-b is not causal in
NK cell activation, but rather that the total amount of IFN-c
produced determines the amount of TGF-b. Thus, activation
may lead to induction of negative feedback mechanisms in
order to prevent excessive pro-inﬂammatory responses.
Discussion
By carefully dissecting the requirements for activation of
human NK cells by iRBCs, we have revealed that the early NK
cell–derived IFN-c response is absolutely dependent upon
contact with, and cytokine production by, accessory cells. We
have identiﬁed the requisite accessory cells as monocytes and
mDCs and have shown that both cell types become highly
activated during the ﬁrst 24 h of exposure to iRBCs.
Furthermore, we have demonstrated that whilst NK cells
provide essential signals that maintain the maturation status
of resting monocytes and mDCs, NK cells are not required for
these same cells to respond fully to iRBCs. Finally, we have
shown that the capacity of NK cells to secrete IFN-c is highly
correlated with both the resting phenotype of the accessory
cells and the concentration of iRBC-induced monokines.
Thus, functional heterogeneity of monocytes and mDCs
among human populations appears to play a crucial role in
determining the magnitude of the innate immune response
to iRBCs.
A wealth of evidence suggests that, after interaction with
malarial parasites, both monocytes and mDCs secrete
immunosuppressive cytokines and have an impaired ability
to respond to a variety of stimulatory ligands [13–17,31].
These data have led some to conclude that monocyte and DC
function is universally impaired by contact with malarial
parasites and that this underlies an apparent suppression of
immune responses seen during malaria infections. However,
there have been several reports of activation of monocytes
and DCs by Plasmodium-derived ligands [32–34]. Studies of
rodent malaria infections have begun to resolve this debate,
showing that in the ﬁrst 24 h of infection, splenic DCs are
activated, secrete pro-inﬂammatory cytokines including IL-12
and tumour necrosis factor-a, and present antigen to T cells,
but that they subsequently become refractory to re-stimula-
tion and secrete anti-inﬂammatory cytokines such as IL-10
[35]. This sequence of events allows infection to be controlled
whilst simultaneously avoiding immune-mediated pathology
[25]. Here we show that human monocytes and mDCs are
highly activated after 24 h of co-incubation with iRBCs. The
myeloid cell response occurred in the presence or absence of
NK cells, indicating that direct interaction with parasites—as
opposed to NK-derived IFN-c—drives the initial activation of
these cells. Furthermore, this activation initiates and regu-
lates the crucial early burst of IFN-c from NK cells. However,
our observation that NK activation goes hand in hand with
IL-10 and TGF-b production, and that TGF-b can suppress
Figure 7. NK Cells Are Required to Maintain Maturation Status of Accessory Cells
Whole PBMCs (closed circles) or NK cell–depleted PBMCs (open circles) were cultured alone or with E. coli LPS or iRBCs for 24 h. The MFIs of CD40, HLA-
DR, and CD80 surface staining on (A) monocytes and (B) mDCs were determined by flow cytometric analysis. *, p , 0.05; p-values are for paired t tests
comparing whole PBMCs with NK cell–depleted PBMCs from the same donor.
doi:10.1371/journal.ppat.0020118.g007
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Accessory Cells in NK Response to P. falciparumNK IFN-c production, is consistent with the notion that pro-
inﬂammatory responses to malaria are carefully regulated by
homeostatic mechanisms to prevent immune-mediated path-
ology.
Our observations regarding the accessory cell requirements
for NK cell activation by malaria parasites are in partial
agreement with a previous report invoking a role for
monocytes in this response [36]; however, we show that
mDCs play an equally important role. The fact that NK
activation is suboptimal but not absent in the presence of
only one or the other accessory cell population suggests that
although there is some redundancy in their roles, they also
provide complementary signals. Our data are consistent with
reports of leukocyte activation by malarial glycosylphospha-
tidylinositol signalling through toll-like receptor (TLR) 2 and
TLR4 [37], which are both expressed on monocytes and mDCs
but not pDCs [38,39], although a role for other receptors
cannot be ruled out. The reported activation of pDCs by a
malarial hemozoin–TLR9 pathway [40,41] does not appear to
be required for NK IFN-c production, consistent with
previous reports that NK cytotoxic activity but not IFN-c
secretion is dependent on pDC-derived signals [42,43]. In fact,
depletion of pDCs increased the IFN-c response of NK cells in
two out of three donors, suggesting that pDCs may have a net
anti-inﬂammatory effect in this system, perhaps mediated by
either IL-10 or TGF-b. Further experiments are required to
test this possibility.
The data presented here reveal that accessory cell–depend-
ent activation of NK cells by iRBCs is multifactorial and, as in
other systems, involves multiple cytokines (IL-2, IL-12, IL-18,
and IFN-a) [44–46] as well as direct contact between NK cells
and accessory cells [12,22,26,27]. Whether accessory cells are
the source of IL-2, as recently reported for human pDCs and
mDCs [47], is not clear, and we cannot rule out that IL-2 is
produced by a small contaminating population of rapidly
responding T cells. Contact-dependent signals might include
CD40–CD40L signalling [12], delivery of IL-12 from mDCs via
an immune synapse [48], or binding of MHC–peptide
complexes by activating KIR [49]. We believe that indirect,
accessory cell–mediated signals are likely to be the major
Figure 8. NK Cell IFN-c Response to iRBCs Correlates with Accessory Cell Activation
NK cell IFN-c responses in PBMCs from eight malaria-naı ¨ve donors were analysed after 24 h of co-culture with iRBCs. The concentration in tissue culture
supernatants of IL-12p70 and IL-2 was determined in a bead-based cytokine assay, and that of bioactive TGF-b by ELISA. The fluorescence intensities of
CD40 and HLA-DR surface staining on CD14
þ monocytes and the percentage of IFN-c
þ CD56
þ NK cells were determined by flow cytometric analysis.
Shown are the percentages of IFN-c
þ CD56
bright NK cells (black squares) and IFN-c
þ CD56
dim NK cells (grey triangles), along with the correlation of the
percentage of IFN-c
þCD56
bright NK cells (black line) with the concentration of IL-12p70 and IL-2 in culture supernatants (A and B), with the MFI of CD40
and HLA-DR on resting monocytes (C and D), and with the up-regulation of bioactive TGF-b in culture supernatants (E). The correlation of TGF-b in
culture supernatants with IFN-c
þ CD56
dim NK cells is also shown (E, grey line). Correlation coefficients are indicated for CD56
bright (upper values) and
CD56
dim (lower values). Correlations were calculated using a second-order polynomial fit algorithm. Black arrows indicate examples of donors where
IFN-c response is highly suppressed in the CD56
dim NK cells. Flow cytometric data are based on the collection of 100,000 total events.
doi:10.1371/journal.ppat.0020118.g008
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Accessory Cells in NK Response to P. falciparummechanism of NK cell activation by iRBCs, but we cannot rule
out that the NK cell receives additional signals via direct
interaction with iRBCs. Stable contacts between iRBCs and
NK cells have been reported by ourselves and by others [9,36],
and we have observed reorganisation of the actin cytoskele-
ton at the point of iRBC–NK contact [9]; the functional
consequence of these interactions are, however, not yet fully
understood.
Our observation that NK cells are not required for optimal
activation of monocytes and mDCs by pathogen-derived
ligands (iRBCs and LPS) runs somewhat counter to previous
reports that NK cells augment DC maturation, cytokine
secretion, and antigen presentation [28–30]. One plausible
explanation for this discrepancy is that the sequence of
events leading to activation of NK cells and accessory cells
depends on the nature of the stimulus. In the case of virally
infected or neoplastic cells, altered expression of MHC or
MHC-like ligands on the target cell will lead to direct
activation of NK cells either through engagement of natural
cytotoxicity receptors or changes in the balance of activating
and inhibitory signals delivered by KIR receptors (reviewed in
[50]). In this case, ampliﬁcation of the innate response and
induction of adaptive immunity would be facilitated if NK
cells were able to provide activating signals to DCs and other
antigen-presenting cells, which are much less sensitive to
changes in MHC expression. On the other hand, in the case of
bacterial and protozoal pathogens, which do not grossly alter
MHC class I expression or induce MHC-related stress ligands
on host cells, direct activation of NK cells is unlikely. Rather,
DCs and monocytes are likely to be directly activated by
binding of pathogen-associated molecular patterns to TLRs
and other pattern recognition receptors and may not require
additional signals from NK cells.
Given the importance of the innate response to malaria in
determining the outcome of disease (reviewed in [1]),
dissecting the basis for the heterogeneity of the human NK
cell response to iRBCs could be crucial in understanding
disease susceptibility. The close correlations shown here
between accessory cell maturation, accessory cell responses to
iRBCs, and induction of IFN-c production by NK cells suggest
that heterogeneity of NK cell responses to iRBCs [8,9] is a
reﬂection of deeply rooted heterogeneity of innate responses
within the human population. Ongoing studies of the
immunogenetics of susceptibility to human malaria should
begin to identify the underlying basis for this heterogeneity,
but linking genotype to immunological phenotype may not
be straightforward. Multiple genes, including various IFN
regulatory factor proteins and components of the colony
stimulating factor 1 signalling pathway, inﬂuence the matu-
ration status of accessory cells [51–53]. Moreover, the much
stronger correlation of accessory cell status with activation of
CD56
bright (KIR
 ) NK cells than with activation of CD56
dim
(KIR
þ) NK cells suggests that NK cell activation by pathogen-
induced accessory cell signals may be modulated by NK cell
receptor expression. Since KIR genes, along with MHC genes,
are some of the most highly polymorphic loci in the human
genome [54], dissecting the genetic basis of diversity in the
human innate response is a daunting task. Nevertheless, as
CD56
dim cells are the major population of NK cells in
peripheral blood and spleen [55], our data suggest that NK
cell receptor expression is likely to have a signiﬁcant
inﬂuence on overall NK cell responsiveness and thus
potentially affect the severity of malarial disease and other
systemic infections. Despite the difﬁculties associated with
carrying them out, population-based studies of disease risk
and diversity in innate response genes could have far-
reaching implications, and we have recently begun such
studies in malaria-endemic populations. Since the antigen-
presenting and co-stimulatory functions of accessory cells are
pivotal for induction of adaptive immunity, and the
magnitude of the early IFN-c response affects adaptive
responses [56], heterogeneity of expression of CD40, HLA-
DR, and NK cell IFN-c is likely to have a profound impact on
the generation of acquired immune responses.
Supporting Information
Figure S1. Depletion of HLA-DR-Positive Cells Does Not Affect the
Ability of NK Cells to Produce IFN-c following Stimulation with IL-12
and IL-18
(A) Representative example of NK cell response to IL-12 and IL-18
when cultured in the context of whole PBMCs or PBMCs depleted of
HLA-DR-positive cells.
(B) Data from ﬁve donors showing proportion of NK cells positive for
intracellular IFN-c following stimulation with IL-12 and IL-18 in the
context of whole PBMCs or PBMCs depleted of HLA-DR-positive
cells. There was no signiﬁcant difference between responses (paired t
test, t ¼ 1.43, p ¼ 0.226).
Found at doi:10.1371/journal.ppat.0020118.sg001 (1.3 MB TIF).
Table 1. Accession Numbers for Genes and Proteins
Protein Ensembl Family/Gene ID
a UniProt ID
b
IL-2 ENSG00000109471 P60568
IL-10 ENSG00000136634 P22301
IL-12p35 ENSG00000168811 P29459
IL-12p40 ENSG00000113302 P29460
IL-15 ENSG00000164136 P40933
IL-18 ENSG00000150782 Q14116
IL-23 ENSG00000110944 Q6NZ80
IFN-a ENSF00000000349 —
IFN-c ENSG00000111537 P01579
TGF-b ENSF00000000951 —
CSF-1 ENSG00000184371 P09603
CD1c ENSG00000158481 P29017
CD3 ENSF00000004297 P04234/P09693
CD11c ENSG00000140678 P20702
CD11b ENSG00000169896 P11215
CD14 ENSG00000170458 P08571
CD19 ENSG00000177455 P15391
CD40 ENSG00000101017 P25942
CD40L ENSG00000102245 P29965
CD56 ENSG00000149294 P13591
CD69 ENSG00000110848 Q07108
CD80 ENSG00000121594 P33681
CD94 ENSG00000134539 Q13241
BDCA-4 ENSG00000099250 O14786
TLR2 ENSG00000137462 O60603
TLR4 ENSG00000136869 O00206
TLR9 ENSG00000173366 Q9NR96
NKG2A ENSG00000134545 P26715
HLA-DR —
c
KIR —
d
ahttp://www.ensembl.org.
bhttp://www.ebi.uniprot.org.
cHLA database, http://www.ebi.ac.uk/imgt/hla.
dKIR database, http://www.ebi.ac.uk/ipd/kir.
CSF1, colony stimulating factor 1.
doi:10.1371/journal.ppat.0020118.t001
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Accessory Cells in NK Response to P. falciparumFigure S2. Staining with Isotype-Matched Control Antibodies Is Not
Affected by Stimulation of Accessory Cells
Representative histograms showing staining of monocytes with (A)
IgG1 and (B) IgG2a antibodies following culture of PBMCs with no
stimulation (gm), LPS, or iRBCs. (C) Pooled data for monocytes
stained for IgG1 following culture with indicated stimuli. (D) Pooled
data for monocytes stained for IgG2a following culture with indicated
stimuli. No signiﬁcant increase in staining intensity of either
antibody was observed after stimulation with E. coli LPS or iRBCs.
Found at doi:10.1371/journal.ppat.0020118.sg002 (385 KB TIF).
Figure S3. Effect of Blocking Antibodies on the NK Cell Response to
iRBCs
Representative FACS plots showing the effect on the NK cell response
to iRBCs of blocking with monoclonal antibodies of the following
speciﬁcities: (A) anti-IL-2, (B) anti-TGF-b, and (C) anti-IFN-a
receptor.
Found at doi:10.1371/journal.ppat.0020118.sg003 (1.4 MB TIF).
Figure S4. Up-Regulation of CD69 on NK Cells in Response to iRBCs
Is Controlled by Type 1 IFN, IL-2, and TGF-b
PBMCs from malaria-naı ¨ve donors were stimulated for 24 h with
iRBCs in the presence of increasing concentrations of neutralising
antibodies to (A) the IFN-a/b receptor, (B) IL-2, (C) IL-15, or (D) TGF-
b. MFI of CD69 on NK cells relative to that observed with the
equivalent concentration of isotype-matched control antibody is
shown.
Found at doi:10.1371/journal.ppat.0020118.sg004 (826 KB TIF).
Figure S5. Diffusion of Soluble Factors through Transwell Membrane
(A) Experimental setup. PBMCs were added to both the inner and
outer compartments of a Transwell. Phytohaemagglutinin (PHA) (a
mitogen) was added to the outer compartment, and the cells were
cultured for 24 h at 37 8C. Cells were aspirated and stained for the
surface markers CD56 and CD3 and intracellular IFN-c.
(B) Proportion of IFN-cþ NK cells amongst PBMCs from outer and
inner compartments following 24 h culture (six donors). There is no
signiﬁcant difference in the response of cells aspirated from the outer
or inner well (paired t test, t ¼ 1.08, p ¼ 0.331).
Found at doi:10.1371/journal.ppat.0020118.sg005 (275 KB TIF).
Accession Numbers
Online database accession and ID numbers for genes and proteins
mentioned throughout this article can be found in Table 1.
Acknowledgments
We would like to thank the London School of Hygiene and Tropical
Medicine blood donors for their participation in this study;
Carolynne Stanley, Elizabeth King, and Nikki D’Arcy for excellent
technical assistance; and Simona Zompi for stimulating discussions.
Author contributions. KCN, DSK, and EMR conceived and
designed the experiments. KCN, DSK, and JCH performed the
experiments. KCN, DSK, and EMR analyzed the data and wrote the
paper.
Funding. DSK was a Boehringer Ingelheim Fonds pre-doctoral
fellow. JCH is a USA Incoming Research Fellow of The Royal Society.
This study was funded by the United Kingdom Medical Research
Council.
Competing interests. The authors have declared that no competing
interests exist.
References
1. Stevenson M, Riley E (2004) Innate immunity to malaria. Nat Rev Immunol
4: 169–180.
2. De Souza JB, Williamson KH, Otani T, Playfair JH (1997) Early gamma
interferon responses in lethal and nonlethal murine blood-stage malaria.
Infect Immun 65: 1593–1598.
3. Su Z, Stevenson MM (2000) Central role of endogenous gamma interferon
in protective immunity against blood-stage Plasmodium chabaudi AS
infection. Infect Immun 68: 4399–4406.
4. Meding SJ, Cheng SC, Simon-Haarhaus B, Langhorne J (1990) Role of
gamma interferon during infection with Plasmodium chabaudi chabaudi.
Infect Immun 58: 3671–3678.
5. Luty AJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, et al. (1999)
Interferon-gamma responses are associated with resistance to reinfection
with Plasmodium falciparum in young African children. J Infect Dis 179: 980–
988.
6. Dodoo D, Omer FM, Todd J, Akanmori BD, Koram KA, et al. (2002)
Absolute levels and ratios of proinﬂammatory and anti-inﬂammatory
cytokine production in vitro predict clinical immunity to Plasmodium
falciparum malaria. J Infect Dis 185: 971–979.
7. Artavanis-Tsakonas K, Riley E (2002) Innate immune response to malaria:
Rapid induction of IFN-gamma from human NK cells by live Plasmodium
falciparum-infected erythrocytes. J Immunol 169: 2956–2963.
8. Artavanis-Tsakonas K, Eleme K, McQueen K, Cheng N, Parham P, et al.
(2003) Activation of a subset of human NK cells upon contact with
Plasmodium falciparum-infected erythrocytes. J Immunol 171: 5396–5405
9. Korbel DS, Newman KC, Almeida CR, Davis DM, Riley EM (2005)
Heterogeneous human NK cell responses to Plasmodium falciparum-infected
erythrocytes. J Immunol 175: 7466–7473.
10. Krug A, French AR, Barchet W, Fischer JA, Dzionek A, et al. (2004) TLR9-
dependent recognition of MCMV by IPC and DC generates coordinated
cytokine responses that activate antiviral NK cell function. Immunity 21:
107–119.
11. Cleveland MG, Gorham JD, Murphy TL, Tuomanen E, Murphy KM (1996)
Lipoteichoic acid preparations of gram-positive bacteria induce interleu-
kin-12 through a CD14-dependent pathway. Infect Immun 64: 1906–1912.
12. Atochina O, Harn D (2005) LNFPIII/LeX-stimulated macrophages activate
natural killer cells via CD40-CD40L interaction. Clin Diagn Lab Immunol
12: 1041–1049.
13. Urban BC, Willcox N, Roberts DJ (2001) A role for CD36 in the regulation
of dendritic cell function. Proc Natl Acad Sci U S A 98: 8750–8755.
14. Deshpande P, Shastry P (2004) Modulation of cytokine proﬁles by malaria
pigment—Hemozoin: Role of IL-10 in suppression of proliferative
responses of mitogen stimulated human PBMC. Cytokine 28: 205–213.
15. Berry A, Chene G, Benoit-Vical F, Lepert JC, Bernad J, et al. (2005) Ex vivo
and in vitro impairment of CD36 expression and tumor necrosis factor-
alpha production in human monocytes in response to Plasmodium
falciparum-parasitized erythrocytes. J Parasitol 91: 316–322.
16. Skorokhod OA, Alessio M, Mordmuller B, Arese P, Schwarzer E (2004)
Hemozoin (malarial pigment) inhibits differentiation and maturation of
human monocyte-derived dendritic cells: A peroxisome proliferator-
activated receptor-gamma-mediated effect. J Immunol 173: 4066–4074.
17. Urban BC, Ferguson DJ, Pain A, Willcox N, Plebanski M, et al. (1999)
Plasmodium falciparum-infected erythrocytes modulate the maturation of
dendritic cells. Nature 400: 73–77.
18. Urban BC, Mwangi T, Ross A, Kinyanjui S, Mosobo M, et al. (2001)
Peripheral blood dendritic cells in children with acute Plasmodium
falciparum malaria. Blood 98: 2859–2861.
19. Gazzinelli RT, Denkers EY, Sher A (1993) Host resistance to Toxoplasma
gondii: Model for studying the selective induction of cell-mediated
immunity by intracellular parasites. Infect Agents Dis 2: 139–149.
20. Hunter CA, Slifer T, Araujo F (1996) Interleukin-12-mediated resistance to
Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma
interferon. Infect Immun 64: 2381–2386.
21. Rottenberg M, Cardoni RL, Andersson R, Segura EL, Orn A (1988) Role of
T helper/inducer cells as well as natural killer cells in resistance to
Trypanosoma cruzi infection. Scand J Immunol 28: 573–582.
22. Siren J, Sareneva T, Pirhonen J, Strengell M, Veckman V, et al. (2004)
Cytokine and contact-dependent activation of natural killer cells by
inﬂuenza A or Sendai virus-infected macrophages. J Gen Virol 85: 2357–
2364.
23. Laouar Y, Sutterwala F, Gorelik L, Flavell R (2005) Transforming growth
factor-beta controls T helper type 1 cell development through regulation
of natural killer cell interferon-gamma. Nat Immunol 6: 600–607.
24. Walther M, Tongren J, Andrews L, Korbel D, King E, et al. (2005)
Upregulation of TGF-beta, FOXP3, and CD4(þ)CD25(þ) regulatory T cells
correlates with more rapid parasite growth in human malaria infection.
Immunity 23: 287–296.
25. Omer F, de Souza JB, Riley E (2003) Differential induction of TGF-beta
regulates proinﬂammatory cytokine production and determines the out-
come of lethal and nonlethal Plasmodium yoelii infections. J Immunol 171:
5430–5436.
26. Cardillo F, Voltarelli JC, Reed SG, Silva JS (1996) Regulation of Trypanosoma
cruzi infection in mice by gamma interferon and interleukin 10: Role of NK
cells. Infect Immun 64: 128–134.
27. Kamath AT, Sheasby CE, Tough DF (2005) Dendritic cells and NK cells
stimulate bystander T cell activation in response to TLR agonists through
secretion of IFN-alpha beta and IFN-gamma. J Immunol 174: 767–776.
28. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, et al. (2002)
Reciprocal activating interaction between natural killer cells and dendritic
cells. J Exp Med 195: 327–333.
29. Vitale M, Della Chiesa M, Carlomagno S, Pende D, Arico M, et al. (2005)
NK-dependent DC maturation is mediated by TNFalpha and IFNgamma
released upon engagement of the NKp30 triggering receptor. Blood 106:
566–571.
30. Piccioli D, Sbrana S, Melandri E, Valiante NM (2002) Contact-dependent
PLoS Pathogens | www.plospathogens.org December 2006 | Volume 2 | Issue 12 | e118 1132
Accessory Cells in NK Response to P. falciparumstimulation and inhibition of dendritic cells by natural killer cells. J Exp
Med 195: 335–341.
31. Schwarzer E, Arese P (1996) Phagocytosis of malarial pigment hemozoin
inhibits NADPH-oxidase activity in human monocyte-derived macro-
phages. Biochim Biophys Acta 1316: 169–175.
32. Ndungu FM, Sanni L, Urban B, Stephens R, Newbold CI, et al. (2006) CD4 T
cells from malaria-nonexposed individuals respond to the CD36-binding
domain of Plasmodium falciparum erythrocyte membrane protein-1 via an
MHC class II-TCR-independent pathway. J Immunol 176: 5504–5512.
33. Pais TF, Chatterjee S (2005) Brain macrophage activation in murine
cerebral malaria precedes accumulation of leukocytes and CD8þ T cell
proliferation. J Neuroimmunol 163: 73–83.
34. Prato M, Giribaldi G, Polimeni M, Gallo V, Arese P (2005) Phagocytosis of
hemozoin enhances matrix metalloproteinase-9 activity and TNF-alpha
production in human monocytes: Role of matrix metalloproteinases in the
pathogenesis of falciparum malaria. J Immunol 175: 6436–6442.
35. Perry JA, Olver CS, Burnett RC, Avery AC (2005) Cutting edge: The
acquisition of TLR tolerance during malaria infection impacts T cell
activation. J Immunol 174: 5921–5925.
36. Baratin M, Roetynck S, Lepolard C, Falk C, Sawadogo S, et al. (2005)
Natural killer cell and macrophage cooperation in MyD88-dependent
innate responses to Plasmodium falciparum. Proc Natl Acad Sci U S A 102:
14747–14752.
37. Krishnegowda G, Hajjar AM, Zhu J, Douglass EJ, Uematsu S, et al. (2005)
Induction of proinﬂammatory responses in macrophages by the glyco-
sylphosphatidylinositols of Plasmodium falciparum: Cell signaling receptors,
glycosylphosphatidylinositol (GPI) structural requirement, and regulation
of GPI activity. J Biol Chem 280: 8606–8616.
38. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, et al. (2001)
Subsets of human dendritic cell precursors express different toll-like
receptors and respond to different microbial antigens. J Exp Med 194: 863–
869.
39. Muzio M, Bosisio D, Polentarutti N, D’Amico G, Stoppacciaro A, et al.
(2000) Differential expression and regulation of toll-like receptors (TLR) in
human leukocytes: Selective expression of TLR3 in dendritic cells. J
Immunol 164: 5998–6004.
40. Pichyangkul S, Yongvanitchit K, Kum-arb U, Hemmi H, Akira S, et al.
(2004) Malaria blood stage parasites activate human plasmacytoid dendritic
cells and murine dendritic cells through a Toll-like receptor 9-dependent
pathway. J Immunol 172: 4926–4933.
41. Coban C, Ishii K, Kawai T, Hemmi H, Sato S, et al. (2005) Toll-like receptor
9 mediates innate immune activation by the malaria pigment hemozoin. J
Exp Med 201: 19–25.
42. Romagnani C, Della Chiesa M, Kohler S, Moewes B, Radbruch A, et al.
(2005) Activation of human NK cells by plasmacytoid dendritic cells and its
modulation by CD4þ T helper cells and CD4þ CD25hi T regulatory cells.
Eur J Immunol 35: 2452–2458.
43. Gerosa F, Gobbi A, Zorzi P, Burg S, Briere F, et al. (2005) The reciprocal
interaction of NK cells with plasmacytoid or myeloid dendritic cells
profoundly affects innate resistance functions. J Immunol 174: 727–734.
44. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP (1999)
Natural killer cells in antiviral defense: Function and regulation by innate
cytokines. Annu Rev Immunol 17: 189–220.
45. Matikainen S, Paananen A, Miettinen M, Kurimoto M, Timonen T, et al.
(2001) IFN-alpha and IL-18 synergistically enhance IFN-gamma production
in human NK cells: Differential regulation of Stat4 activation and IFN-
gamma gene expression by IFN-alpha and IL-12. Eur J Immunol 31: 2236–
2245.
46. Naume B, Espevik T (1994) Immunoregulatory effects of cytokines on
natural killer cells. Scand J Immunol 40: 128–134.
47. Feau S, Facchinetti V, Granucci F, Citterio S, Jarrossay D, et al. (2005)
Dendritic cell-derived IL-2 production is regulated by IL-15 in humans and
in mice. Blood 105: 697–702.
48. Borg C, Jalil A, Laderach D, Maruyama K, Wakasugi H, et al. (2004) NK cell
activation by dendritic cells (DCs) requires the formation of a synapse
leading to IL-12 polarization in DCs. Blood 104: 3267–3275.
49. Stewart CA, Laugier-Anfossi F, Vely F, Saulquin X, Riedmuller J, et al.
(2005) Recognition of peptide-MHC class I complexes by activating killer
immunoglobulin-like receptors. Proc Natl Acad Sci U S A 102: 13224–
13229.
50. O’Connor GM, Hart OM, Gardiner CM (2006) Putting the natural killer cell
in its place. Immunology 117: 1–10.
51. Dey A, She H, Kim L, Boruch A, Guris DL, et al. (2000) Colony-stimulating
factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2
expression. Mol Biol Cell 11: 3835–3848.
52. Zhang DE, Hetherington CJ, Meyers S, Rhoades KL, Larson CJ, et al. (1996)
CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2)
synergistically activate the macrophage colony-stimulating factor receptor
promoter. Mol Cell Biol 16: 1231–1240.
53. Tamura T, Nagamura-Inoue T, Shmeltzer Z, Kuwata T, Ozato K (2000)
ICSBP directs bipotential myeloid progenitor cells to differentiate into
mature macrophages. Immunity 13: 155–165.
54. Norman PJ, Parham P (2005) Complex interactions: The immunogenetics
of human leukocyte antigen and killer cell immunoglobulin-like receptors.
Semin Hematol 42: 65–75.
55. Ferlazzo G, Mu ¨nz C (2004) NK cell compartments and their activation by
dendritic cells. J Immunol 172: 1333–1339.
56. Mitchell AJ, Hansen AM, Hee L, Ball HJ, Potter SM, et al. (2005) Early
cytokine production is associated with protection from murine cerebral
malaria. Infect Immun 73: 5645–5653.
PLoS Pathogens | www.plospathogens.org December 2006 | Volume 2 | Issue 12 | e118 1133
Accessory Cells in NK Response to P. falciparum